Intervention eliminates Black-white gaps in survival from early-stage breast and lung cancer

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

The Accountability for Cancer Care through Undoing Racism and Equity (ACCURE) clinical trial—a prospective study designed to reduce gaps in cancer treatment completion and survival among Black and white patient populations— found that identifying and addressing obstacles that kept patients from finishing radiation treatments improved five-year survival rates for all patients and erased the survival gap between Black and white patients.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Table of Contents

YOU MAY BE INTERESTED IN

Multiple components of the healthcare and public health systems are currently under scrutiny. One of them is reportedly the U.S. Preventive Services Task Force (USPSTF: “Task Force”), established in 1984 and managed by the Agency for Healthcare Research and Quality.  It was created to maintain an ongoing evaluation of disease prevention and screening interventions that...

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login